Cha Biotech to Acquire Additional Cha Healthcare Shares for 153.9 Billion Won
Cha Biotech announced on June 26 that it will acquire an additional 5,919,732 shares of Cha Healthcare, its overseas healthcare network operation and investment development subsidiary, for approximately 153.9 billion won. After the acquisition, Cha Biotech's stake in Cha Healthcare will increase to 81.7%.
Hot Picks Today
"We'll Pay 100% of Bonuses in Stock, Not Cash"...Employees Voting at This Company
- "Losing Jobs and Selling Bean Sprouts: Why They Left a Job Earning 6.76 Million Won per Month"
- "How Much Further Can It Fall?" Balances Fluctuate as KOSPI Drops 5% After Two Days of Gains
- Cardiac Arrests Surge in 40-Degree Heatwave, Hospitals Overwhelmed... Paris Issues Emergency "No Drinking" Ban
- "‘Hong Myungbo Banned from Entry’ Posted on Convenience Store Door... Headquarters Investigating Store Location"
Cha Biotech explained that this share acquisition is "a precedent condition under the share purchase agreement to transfer part of the shares held in our subsidiary, Cha Healthcare Co., Ltd., to the PiumAI Future Healthcare Fund."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
